PL1991225T3 - Zastosowanie deferypronu i sposobów w leczeniu i/lub zapobieganiu ataksji Friedreicha związanej z wewnątrzkomórkową nieprawidłową gospodarką żelazem - Google Patents

Zastosowanie deferypronu i sposobów w leczeniu i/lub zapobieganiu ataksji Friedreicha związanej z wewnątrzkomórkową nieprawidłową gospodarką żelazem

Info

Publication number
PL1991225T3
PL1991225T3 PL07701800T PL07701800T PL1991225T3 PL 1991225 T3 PL1991225 T3 PL 1991225T3 PL 07701800 T PL07701800 T PL 07701800T PL 07701800 T PL07701800 T PL 07701800T PL 1991225 T3 PL1991225 T3 PL 1991225T3
Authority
PL
Poland
Prior art keywords
deferiprone
treat
iron
methods
friedreich ataxia
Prior art date
Application number
PL07701800T
Other languages
English (en)
Inventor
Arnold Munnich
Michael Spino
Ioav Cabantchik
Original Assignee
Apotex Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotex Tech Inc filed Critical Apotex Tech Inc
Publication of PL1991225T3 publication Critical patent/PL1991225T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/04—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL07701800T 2006-02-22 2007-02-21 Zastosowanie deferypronu i sposobów w leczeniu i/lub zapobieganiu ataksji Friedreicha związanej z wewnątrzkomórkową nieprawidłową gospodarką żelazem PL1991225T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77532006P 2006-02-22 2006-02-22
PCT/CA2007/000252 WO2007095728A1 (en) 2006-02-22 2007-02-21 The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron
EP07701800.0A EP1991225B1 (en) 2006-02-22 2007-02-21 The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron

Publications (1)

Publication Number Publication Date
PL1991225T3 true PL1991225T3 (pl) 2014-04-30

Family

ID=38436879

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07701800T PL1991225T3 (pl) 2006-02-22 2007-02-21 Zastosowanie deferypronu i sposobów w leczeniu i/lub zapobieganiu ataksji Friedreicha związanej z wewnątrzkomórkową nieprawidłową gospodarką żelazem

Country Status (24)

Country Link
US (3) US20090023784A1 (pl)
EP (1) EP1991225B1 (pl)
JP (1) JP5730466B2 (pl)
KR (1) KR20080104329A (pl)
CN (1) CN101420954A (pl)
AU (1) AU2007219009B2 (pl)
BR (1) BRPI0708211A2 (pl)
CA (1) CA2642778A1 (pl)
DK (1) DK1991225T3 (pl)
ES (1) ES2441065T3 (pl)
IL (1) IL193598A (pl)
MA (1) MA30266B1 (pl)
MX (1) MX2008010824A (pl)
MY (1) MY151412A (pl)
NZ (1) NZ570730A (pl)
PL (1) PL1991225T3 (pl)
PT (1) PT1991225E (pl)
RS (1) RS53225B (pl)
RU (1) RU2008137604A (pl)
SG (1) SG170020A1 (pl)
SI (1) SI1991225T1 (pl)
TN (1) TNSN08338A1 (pl)
UA (1) UA95099C2 (pl)
WO (1) WO2007095728A1 (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007095728A1 (en) * 2006-02-22 2007-08-30 Arnold Munnich The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron
CN101679263B (zh) 2007-03-28 2014-01-15 阿普泰克斯科技公司 去铁酮的氟化衍生物
EP2268282B1 (en) * 2008-04-25 2014-10-29 Apotex Technologies Inc. Liquid formulation for deferiprone with palatable taste
CA2750599A1 (en) * 2009-01-26 2010-07-29 Michael Spino Use of deferiprone for treatment and prevention of iron-related eye disorders
GEP20146008B (en) 2009-07-03 2014-01-10 Apotex Tech Inc Fluorinated derivatives of 3-hydroxypyridin-4-ones
EP2959902A1 (en) 2009-07-23 2015-12-30 Novartis AG Use of azabicycloalkyl derivatives for the treatment or prevention of ataxia
JO3250B1 (ar) 2009-09-22 2018-09-16 Novartis Ag إستعمال منشطات مستقبل نيكوتينيك أسيتيل كولين ألفا 7
CA2809747C (en) * 2010-08-30 2018-05-01 Roberto Testi Compositions and methods for treating friedreich's ataxia with interferon gamma
CN102861017A (zh) * 2011-07-08 2013-01-09 辽宁省计划生育科学研究院 一种化合物在防治老年痴呆的应用
WO2013139931A1 (en) * 2012-03-21 2013-09-26 Icm (Institut Du Cerveau Et De La Moelle Épinière) Composition for use in the treatment of neurodegenerative diseases with parkinsonian syndromes
US10442779B2 (en) 2014-09-22 2019-10-15 Fratagene Therapeutics S.R.L. Compositions and methods for treating Friedreich's ataxia
US10426775B2 (en) 2017-09-11 2019-10-01 Fratagene Therapeutics Srl Methods for treating Friedreich's ataxia with etravirine
MD3684344T2 (ro) 2017-10-25 2025-09-30 Chiesi Farm Spa Comprimate de deferipronă cu eliberare întârziată și metode de utilizare a acestora
US12016851B2 (en) 2022-04-11 2024-06-25 Chiesi Farmaceutici S.P.A. Modified release pharmaceutical formulations comprising deferiprone
US12016850B2 (en) 2022-04-11 2024-06-25 Chiesi Farmaceutici S.P.A. Modified release pharmaceutical formulations comprising deferiprone
EP4734990A1 (en) * 2023-06-28 2026-05-06 The United States of America, as Represented By the Secretary, Department of Health and Human Services Uses of iron chelators for treating stuttering

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624807A (en) * 1992-07-22 1997-04-29 The Mclean Hospital Corporation Methods for detecting Alzheimer's disease by measuring ratios of calcium-activated neutral protease isoforms
US6472378B2 (en) * 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
CA2272971C (en) 1998-10-29 2008-01-15 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quinone derivatives for treating or preventing diseases associated with iron overload
US6933104B1 (en) * 1999-04-23 2005-08-23 Shiva Biomedical, Llc Diagnosis and treatment of human kidney diseases
AUPQ262499A0 (en) 1999-09-02 1999-09-23 University Of Queensland, The Novel iron chelators
CA2313270C (en) * 2000-06-30 2011-09-13 Apotex Inc. Use of deferiprone in treating and preventing iron-induced cardiac disease
US20040101521A1 (en) * 2002-07-12 2004-05-27 The Buck Institute For Research On Aging Iron sequestration or elimination to reduce neurodegeneration or Parkinsons disease progression
EP1565185A4 (en) * 2002-11-07 2011-01-05 Technion Res & Dev Foundation NEUROPROTECTIVE IRON CHELATORS AND PHARMACEUTICAL COMPOSITIONS THEREWITH
US9737511B2 (en) * 2004-05-24 2017-08-22 Geoffrey C. GURTNER Method of treating or preventing pathologic effects of acute increases in hyperglycemia and/or acute increases of free fatty acid flux
JP2008500347A (ja) * 2004-05-24 2008-01-10 ニュー・ヨーク・ユニヴァーシティー 高血糖症による血糖の急激な増加及び／又は急激な遊離脂肪酸流動の増加の病理学的影響の治療方法又は予防方法
US7728038B2 (en) * 2004-08-04 2010-06-01 University Of Utah Research Foundation Methods for chelation therapy
US20070197469A1 (en) * 2006-02-17 2007-08-23 Murthy Yerramilli V Fluoroquinolone carboxylic acid salt compositions
WO2007095728A1 (en) * 2006-02-22 2007-08-30 Arnold Munnich The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron

Also Published As

Publication number Publication date
US20070197649A1 (en) 2007-08-23
AU2007219009A1 (en) 2007-08-30
MX2008010824A (es) 2009-06-08
IL193598A (en) 2012-08-30
CN101420954A (zh) 2009-04-29
AU2007219009B2 (en) 2012-12-20
KR20080104329A (ko) 2008-12-02
ES2441065T3 (es) 2014-01-31
PT1991225E (pt) 2014-02-13
RS53225B (sr) 2014-08-29
JP2009527506A (ja) 2009-07-30
IL193598A0 (en) 2009-08-03
DK1991225T3 (da) 2013-12-16
BRPI0708211A2 (pt) 2011-05-17
JP5730466B2 (ja) 2015-06-10
SG170020A1 (en) 2011-04-29
US20090023784A1 (en) 2009-01-22
EP1991225A1 (en) 2008-11-19
WO2007095728A1 (en) 2007-08-30
EP1991225A4 (en) 2009-07-29
MY151412A (en) 2014-05-30
TNSN08338A1 (en) 2009-12-29
US20130190365A1 (en) 2013-07-25
SI1991225T1 (sl) 2014-02-28
CA2642778A1 (en) 2007-08-30
MA30266B1 (fr) 2009-03-02
UA95099C2 (ru) 2011-07-11
EP1991225B1 (en) 2013-11-06
NZ570730A (en) 2013-05-31
RU2008137604A (ru) 2010-03-27

Similar Documents

Publication Publication Date Title
IL193598A0 (en) The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron
EP2129677A4 (en) HETEROCYCLIC CYCLOPAMINE ANALOGUES AND METHODS OF USE
EG25839A (en) Consolidating agent emulsions and associated methods
IL200186A0 (en) Activin-actriia antagonists and uses for treating or preventing breast cancer
IL197276A0 (en) Methods of inhibiting angiogenesis and treating angiogenesis associated diseases
PL2318033T3 (pl) Kompozycje do leczenia bólu i/lub stanu zapalnego
BRPI1011818A2 (pt) "método de tratamento de câncer com antagonista de dll4 e agente quimioterapêutico"
ZA200901553B (en) Pest control agent in form of stable suspension
EP2268281A4 (en) THIENOPYRROLES AND PYRROLOTHIAZOLES AS NEW THERAPEUTIC AGENTS
EP2400980A4 (en) THERAPEUTIC VISCATINIUM AGENTS FOR THE TREATMENT OF ACNE AND OTHERS
PL381862A1 (pl) Zastosowanie związków pirydyniowych i sposób leczenia
EP2084165A4 (en) PRO-DRUGS OF WATER-SOLUBLE OXICAMS POSITIVE AND RELATED COMPOUNDS WITH VERY HIGH SKIN PENETRATION SPEED
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
GB0718918D0 (en) Compositions and methods for treating skin conditions
ZA200908989B (en) Enhancement of the efficacy of therapeutic proteins
IL200966A0 (en) Tetrahydroquinoline derivatives and the use thereof for the treatment of cancer
PT2046118E (pt) Composição herbicida e método de utilização da mesma
EP2100588A4 (en) PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST ALOPEY
HK1125846A (en) The use of deferiprone and methods to treat and/or prevent friedreich ataxia resulting from intracellular mishandling of iron
EP2059621A4 (en) TEMPERATURE STABLE CAST ALLOY AND USE THEREOF
ZA201006660B (en) "agent for preventing and/or treating vascular diseases"
ZA200707487B (en) Enhanced delivery of skin benefit agents
GB0613028D0 (en) Hair straightening iron with ionic treatment
GB0814582D0 (en) Herbicidal composition and method of use thereof
GB0814583D0 (en) Herbicidal composition and method of use thereof